Join Us Again in Philadelphia on August 7-9! Visit Immuno-OncologySummit.com for more information.

Missed Immuno-Oncology Summit Europe This Year?

Access Digital Platform

Missed this year's event? Access content across all of this year's programs on-demand. At your convenience, access archived presentations for on-demand learning, from anywhere, at any time.

Conference Programs Covering the Latest Immuno-Oncology Developments

Experience the Future of Immuno-Oncology

Welcome to Immuno-Oncology Summit Europe 2024


Now into our 8th year, CHI’s Immuno-Oncology Summit Europe is the premier event for immuno-oncology professionals who want to learn about the latest advancements and innovations in the field. The Summit will take place on 23-25 April 2024 in London, one of the world’s leading hubs for biomedical research and clinical development.

With a comprehensive agenda encompassing four distinct yet related programs - Modulating the Tumour Microenvironment, Next Generation Cell-Based Immunotherapies, Bispecific and Multi-specific Antibody Therapeutics and Therapeutic Cancer Vaccines, the Summit promises to be a forum for the exchange of cutting-edge research, and a platform for collaboration among the global immuno-oncology community.

Highlights include a plenary keynote session featuring 2 distinguished speakers; engaging breakout discussions that bring peers together to chat about the most pressing or contentious topics; a balanced faculty of industry and academia speakers; posters showcasing innovative studies and an Exhibit Hall gathering the technology leaders in the IO space.

Join us at the Immuno-Oncology Summit Europe 2024 to meet peers, exchange ideas, and find collaborators to accelerate your next IO program.

Register Now
Preliminary Agenda
Present a Research Poster
Sponsor and Exhibit

2024 Plenary Keynote Speakers

George Coukos, MD, PhD

TIL-Therapy — Lessons for Future Development

George Coukos, MD, PhD
Director, Oncology, Ludwig Institute for Cancer Research; Professor, Oncology, University Hospital (CHUV) and University of Lausanne (UNIL)

Joanna Brewer, PhD

Afami-cel: The Journey from TCR Engineering Towards Commercial Cell Therapy

Joanna Brewer, PhD
CSO, Adaptimmune R&D

Featured Speakers

Sergio A. Quezada, PhD

Sergio A. Quezada, PhD
Professor, Cancer Immunology & Immunotherapy, University College London

Dario Neri, PhD

Dario Neri, PhD
CEO and CSO, Philogen; Professor, Chemistry and Applied Biosciences, ETH Zurich

Harald Kolmar, PhD

Harald Kolmar, PhD
Professor and Head, Institute for Organic Chemistry and Biochemistry, Technische Universität Darmstadt

Sjoerd H. Van Der Burg, PhD

Sjoerd H. Van Der Burg, PhD
Head, Experimental Cancer Immunology and Therapy Group, Leiden University Medical Center

Praveen Aanur

Praveen Aanur
Therapeutic Area Head, Oncology, Moderna Inc.

Mark L. Chiu, PhD

Mark L. Chiu, PhD
CSO, Tavotek Biotherapeutics

Connect With Us


For meeting questions or suggestions, please contact:

Mimi Langley
Senior Conference Director
Cambridge Healthtech Institute
+1 781.972.5439


For partnering and sponsorship info, please contact:

Phillip Zakim-Yacouby
Senior Business Development Manager
Cambridge Healthtech Institute
+1 781.247.1815


For media and association partnerships, please contact:

Christine Benners
Senior Marketing Manager
Cambridge Healthtech Institute
+1 781.247.1820